Weight Loss Stocks Could Become Alzheimer’s Drugs Stocks. Here’s Why That’s Bullish for Novo Nordisk
The company’s addressable market could eventually be expanded even more.
American Express Stock Hit an All-Time High Recently: My Prediction for What Comes Next
The credit card giant continues to win among younger shoppers.
Some Americans Are Already Done Paying Social Security Tax for the Year. Here’s Why.
If you make a lot of money, you may have fulfilled your obligations to pay Social Security benefits already in 2024. Here’s why that’s the case.
Why the Good ‘Ol Days May Not Return for CrowdStrike Stock
CrowdStrike isn’t out of the woods just yet.
Can NIO Succeed Where Rivals Have Failed? So Far, So Good.
When it comes to competitive advantages in the EV industry, few have the potential of NIO.
#426: Recursion And Exscientia Are Merging To Form An AI-Enabled Drug Discovery Powerhouse, & More
Last week, Recursion and Exscientia agreed to a merger that we believe is a visionary step forward in the AI-driven transformation of drug discovery. Uniting Recursion’s pioneering biological exploration capabilities with Exscientia’s AI precision chemistry, the partnership could catapult the biopharma industry into a new way of discovering and developing medicines.
#426: Recursion And Exscientia Are Merging To Form An AI-Enabled Drug Discovery Powerhouse, & More
Last week, Recursion and Exscientia agreed to a merger that we believe is a visionary step forward in the AI-driven transformation of drug discovery. Uniting Recursion’s pioneering biological exploration capabilities with Exscientia’s AI precision chem…
Shopify Stock: Buy, Hold or Sell?
Shopify is quietly becoming a global e-commerce giant — and more.